What is N-Acetyl Semax Amidate?

It is a chemically modified analogue of Semax, a peptide derived from an ACTH fragment. The N-acetyl and amidate modifications are intended to improve stability, and it is discussed primarily as a cognitive or nootropic peptide.

What does research suggest N-Acetyl Semax Amidate does?

Discussion centers on BDNF modulation and neuroprotective signalling, with preclinical cognitive effects reported for the Semax family. Direct human evidence for this specific analogue is limited and largely extrapolated from standard Semax research.

Is N-Acetyl Semax Amidate approved or a medicine?

No. It is not approved in the EU or US. It is related to Semax, which is a prescription medicine in some countries, but the acetylated-amidated variant itself has not been through clinical approval anywhere.

Is N-Acetyl Semax Amidate safe?

Its safety is not established. It is sold on the research-chemical market where purity is unverified, and it has not been validated as a therapy. Any use carries unknown risk and should involve a qualified healthcare professional.

What are the reported side effects?

Nasal irritation has been reported with intranasal use. Because rigorous human safety data on this specific analogue is lacking, the full side-effect profile is not well characterized.

What is the legal status of N-Acetyl Semax Amidate?

It is not an approved medicine in the EU or US and is generally supplied only as a research chemical. Legal status varies by country, so anyone should check the rules in their own jurisdiction.

How does N-Acetyl Semax Amidate differ from regular Semax?

The two share the same core Semax sequence, but the amidate analogue is chemically modified at both ends of the molecule: the N-terminus is acetylated and the C-terminus is amidated. These changes are intended to make the peptide more resistant to enzymatic breakdown, so it is often described as a more stable variant. Importantly, the large body of published clinical work belongs to the original Semax used in Russia, not to this modified form, so evidence does not automatically transfer between them.

Why is the compound often discussed alongside terms like BDNF and neurotrophic signalling?

Much of the online discussion of the Semax family centres on proposed effects on brain-derived neurotrophic factor (BDNF) and related neuroprotective signalling, which appear in preclinical animal work on the parent peptide. This is the origin of its reputation in cognitive-enhancement circles. It is worth treating these as proposed mechanisms discussed in the literature rather than proven effects in humans for this specific analogue, which has limited independent evidence.

A common misconception is that because Semax is an approved medicine somewhere, this variant is too. Is that accurate?

No. Semax is registered as a medicine in some countries, notably Russia, but that regulatory status applies to the original compound in specific formulations and indications. N-Acetyl Semax Amidate is a distinct, modified analogue that is not an approved medicine in the EU or US and is generally sold only as a research chemical. Regulatory approval of a parent drug does not extend to a chemically altered derivative.

Where can I buy N-Acetyl Semax Amidate and compare vendors?

Use the vendor comparison on this page. It shows only checked, product-specific links and identifies vendor claims, independent documentation and affiliate relationships separately. Availability and legal status can vary by country.

Cognitive

Buy N-Acetyl Semax Amidate – Vendors, Prices, Testing and Evidence

Buy N-Acetyl Semax Amidate

Also known as: NA-Semax · NASA

Evidence grade C — Early / Preclinical

Short answer

A more stable amidated variant of Semax discussed for cognition. Limited independent evidence.

Where can you buy N-Acetyl Semax Amidate?

No peptide-specific vendor offer is currently verified. The vendor catalogue link is provided for discovery only and does not assert availability.

What is known?

An acetylated, amidated analogue of Semax intended for greater stability.

What is not established?

Limited; extrapolated largely from Semax research.

Safety

Research-market purity is unverified; not a validated therapy.

Regulatory status

Not approved in the EU/US; related to a medicine used in some countries.

Not medical advice. This educational reference is not diagnosis, treatment, prescribing, dosing or emergency guidance. Consult a qualified professional before making health-related decisions.

Vendor comparison

Buy N-Acetyl Semax Amidate: compare vendors

The table lists only product-specific offers that were checked and for which a real destination exists. Missing prices, quantities, stock and laboratory details are not inferred.

What is it?

An acetylated, amidated analogue of Semax intended for greater stability.

Research and evidence

N-Acetyl Semax Amidate, commonly abbreviated NA-Semax or NASA, is a chemically modified analogue of Semax, itself a synthetic peptide derived from a fragment of the hormone ACTH (4-10). The "N-acetyl" and "amidate" modifications refer to changes at the peptide's terminal ends that are intended to slow enzymatic breakdown, giving the molecule greater metabolic stability than unmodified Semax. Categorized as a cognitive or nootropic peptide, it is most often discussed in research and self-experimentation communities in the context of focus, attention and neuroprotection. It is important to understand that N-Acetyl Semax Amidate is not an approved medicine in the EU or US; it is related to Semax, which is used as a prescription medicine in a small number of countries, but the acetylated-amidated variant itself has not gone through the clinical approval process anywhere.

The scientific rationale most frequently cited for the Semax family centers on modulation of brain-derived neurotrophic factor (BDNF) and related neurotrophic and neuroprotective signalling pathways. These mechanisms are plausible and are actively discussed in the literature, but the direct human evidence for N-Acetyl Semax Amidate specifically is limited. Most claims are extrapolated from research on standard Semax rather than derived from controlled trials of the amidated analogue, and the preclinical (animal) cognitive effects that are reported apply to the broader Semax family rather than establishing outcomes for this particular molecule. In short, the peptide is interesting to researchers because of a coherent biological story and a related medicine used abroad, but independent, high-quality human data on N-Acetyl Semax Amidate itself remains sparse. peptides.cx assigns it a lower-confidence evidence grade to reflect this gap.

On safety and legality, an honest picture matters. Because N-Acetyl Semax Amidate is sold on the research-chemical market rather than as a regulated pharmaceutical, product purity, identity and concentration are unverified and can vary between suppliers. It has not been validated as a therapy, and reported adverse effects include nasal irritation when used intranasally. This page is an educational reference intended to summarize what the available evidence does and does not show; it is not medical advice, and it does not provide dosing, protocols or sourcing guidance. Anyone considering peptides for any purpose should consult a qualified healthcare professional and be aware of the regulatory status in their own jurisdiction.

Evidence grade: C

Limited; extrapolated largely from Semax research. Preclinical cognitive effects reported for the Semax family.

Human evidence

Limited; extrapolated largely from Semax research.

Animal and preclinical evidence

Preclinical cognitive effects reported for the Semax family.

Proposed mechanisms

Discussed BDNF modulation
Proposed neuroprotective signalling

Safety concerns and known side effects

Research-market purity is unverified; not a validated therapy.

Nasal irritation with intranasal use reported

Regulatory status

Not approved in the EU/US; related to a medicine used in some countries.

N-Acetyl Semax Amidate research timeline

1980s
Soviet researchers at the Institute of Molecular Genetics (Russian Academy of Sciences) develop Semax, a short peptide derived from a fragment of the ACTH(4-10) hormone sequence, as a non-hormonal neuroactive compound.
1990s
Semax itself is registered and used as a medicine in Russia for indications such as stroke recovery and cognitive support; this parent compound, not the amidated analogue, is the source of most published clinical claims.
2000s
Preclinical and mechanistic work on the Semax family reports effects associated with BDNF and neurotrophic signalling in animal models, building the rationale later borrowed by analogues.
2010s
N-Acetyl Semax Amidate emerges as a chemically modified analogue, with an acetylated N-terminus and amidated C-terminus intended to slow enzymatic breakdown and improve stability; it circulates chiefly through research-chemical and nootropic markets rather than through formal drug development.
early 2020s
Interest grows online among nootropic communities, but independent human trials specific to the acetylated-amidated variant remain scarce, with most claims extrapolated from Semax rather than tested directly.
2020s (ongoing)
The compound remains unapproved as a medicine in the EU and US and is sold only as a research chemical; no major regulatory approval, and material purity from research suppliers is not independently guaranteed.

Frequently asked questions about N-Acetyl Semax Amidate

What is N-Acetyl Semax Amidate?: It is a chemically modified analogue of Semax, a peptide derived from an ACTH fragment. The N-acetyl and amidate modifications are intended to improve stability, and it is discussed primarily as a cognitive or nootropic peptide.
What does research suggest N-Acetyl Semax Amidate does?: Discussion centers on BDNF modulation and neuroprotective signalling, with preclinical cognitive effects reported for the Semax family. Direct human evidence for this specific analogue is limited and largely extrapolated from standard Semax research.
Is N-Acetyl Semax Amidate approved or a medicine?: No. It is not approved in the EU or US. It is related to Semax, which is a prescription medicine in some countries, but the acetylated-amidated variant itself has not been through clinical approval anywhere.
Is N-Acetyl Semax Amidate safe?: Its safety is not established. It is sold on the research-chemical market where purity is unverified, and it has not been validated as a therapy. Any use carries unknown risk and should involve a qualified healthcare professional.
What are the reported side effects?: Nasal irritation has been reported with intranasal use. Because rigorous human safety data on this specific analogue is lacking, the full side-effect profile is not well characterized.
What is the legal status of N-Acetyl Semax Amidate?: It is not an approved medicine in the EU or US and is generally supplied only as a research chemical. Legal status varies by country, so anyone should check the rules in their own jurisdiction.
How does N-Acetyl Semax Amidate differ from regular Semax?: The two share the same core Semax sequence, but the amidate analogue is chemically modified at both ends of the molecule: the N-terminus is acetylated and the C-terminus is amidated. These changes are intended to make the peptide more resistant to enzymatic breakdown, so it is often described as a more stable variant. Importantly, the large body of published clinical work belongs to the original Semax used in Russia, not to this modified form, so evidence does not automatically transfer between them.
Why is the compound often discussed alongside terms like BDNF and neurotrophic signalling?: Much of the online discussion of the Semax family centres on proposed effects on brain-derived neurotrophic factor (BDNF) and related neuroprotective signalling, which appear in preclinical animal work on the parent peptide. This is the origin of its reputation in cognitive-enhancement circles. It is worth treating these as proposed mechanisms discussed in the literature rather than proven effects in humans for this specific analogue, which has limited independent evidence.
A common misconception is that because Semax is an approved medicine somewhere, this variant is too. Is that accurate?: No. Semax is registered as a medicine in some countries, notably Russia, but that regulatory status applies to the original compound in specific formulations and indications. N-Acetyl Semax Amidate is a distinct, modified analogue that is not an approved medicine in the EU or US and is generally sold only as a research chemical. Regulatory approval of a parent drug does not extend to a chemically altered derivative.
Where can I buy N-Acetyl Semax Amidate and compare vendors?: Use the vendor comparison on this page. It shows only checked, product-specific links and identifies vendor claims, independent documentation and affiliate relationships separately. Availability and legal status can vary by country.

Common discussion areas

FocusSemax family

Sources

No suitable primary study or review specific to this entry was identified during the last editorial review.

Editorial review and transparency

Written by: peptides.cx Editorial Team
Scientific reviewer: No named medical reviewer is currently assigned
Last editorial review: June 1, 2026
Last vendor check: July 18, 2026
Review method: Source review, claim verification, vendor-data separation and regulatory-context review.
Commercial disclosure and conflicts: Vendor relationships do not determine evidence or safety ratings. No named reviewer conflict is recorded because no named reviewer is assigned.

Editorial policy →Evidence grade →Vendor methodology →

Related on peptides.cx

Library →Vendor quality checklist →Safety →Affiliate code: PEPTIDES10